38 research outputs found
Comorbidities of COPD
International audienceBy 2020, chronic obstructive pulmonary disease (COPD) will be the third cause of mortality. Extrapulmonary comorbidities influence the prognosis of patients with COPD. Tobacco smoking is a common risk factor for many comorbidities, including coronary heart disease, heart failure and lung cancer. Comorbidities such as pulmonary artery disease and malnutrition are directly caused by COPD, whereas others, such as systemic venous thromboembolism, anxiety, depression, osteoporosis, obesity, metabolic syndrome, diabetes, sleep disturbance and anaemia, have no evident physiopathological relationship with COPD. The common ground between most of these extrapulmonary manifestations is chronic systemic inflammation. All of these diseases potentiate the morbidity of COPD, leading to increased hospitalisations and healthcare costs. They can frequently cause death, independently of respiratory failure. Comorbidities make the management of COPD difficult and need to be evaluated and treated adequately. Extrapulmonary comorbidities are common in COPD and influence prognosis; we propose an exhaustive comorbidities revie
The Complete Genome of Propionibacterium freudenreichii CIRM-BIA1T, a Hardy Actinobacterium with Food and Probiotic Applications
Background: Propionibacterium freudenreichii is essential as a ripening culture in Swiss-type cheeses and is also considered for its probiotic use [1]. This species exhibits slow growth, low nutritional requirements, and hardiness in many habitats. It belongs to the taxonomic group of dairy propionibacteria, in contrast to the cutaneous species P. acnes. The genome of the type strain, P. freudenreichii subsp. shermanii CIRM-BIA1 (CIP 103027T), was sequenced with an 11-fold coverage. Methodology/Principal Findings: The circular chromosome of 2.7 Mb of the CIRM-BIA1 strain has a GC-content of 67% and contains 22 different insertion sequences (3.5% of the genome in base pairs). Using a proteomic approach, 490 of the 2439 predicted proteins were confirmed. The annotation revealed the genetic basis for the hardiness of P. freudenreichii, as the bacterium possesses a complete enzymatic arsenal for de novo biosynthesis of aminoacids and vitamins (except panthotenate and biotin) as well as sequences involved in metabolism of various carbon sources, immunity against phages, duplicated chaperone genes and, interestingly, genes involved in the management of polyphosphate, glycogen and trehalose storage. The complete biosynthesis pathway for a bifidogenic compound is described, as well as a high number of surface proteins involved in interactions with the host and present in other probiotic bacteria. By comparative genomics, no pathogenicity factors found in P. acnes or in other pathogenic microbial species were identified in P. freudenreichii, which is consistent with the Generally Recognized As Safe and Qualified Presumption of Safety status of P. freudenreichii. Various pathways for formation of cheese flavor compounds were identified: the Wood-Werkman cycle for propionic acid formation, amino acid degradation pathways resulting in the formation of volatile branched chain fatty acids, and esterases involved in the formation of free fatty acids and esters. Conclusions/Significance: With the exception of its ability to degrade lactose, P. freudenreichii seems poorly adapted to dairy niches. This genome annotation opens up new prospects for the understanding of the P. freudenreichii probiotic activity
Intérêt des rapports d'autoPPC dans le suivi des patients traités pour un syndrome d'apnées obstructives du sommeil
POITIERS-BU MĂ©decine pharmacie (861942103) / SudocPARIS-BIUM (751062103) / SudocSudocFranceF
Prise en charge par les médecins généralistes de la surveillance du traitement par pression positive continue au cours du syndrome d'apnées obstructives du sommeil
POITIERS-BU MĂ©decine pharmacie (861942103) / SudocSudocFranceF
Résistances et collapsibilité des voies aériennes supérieures (différences hommes/femmes)
POITIERS-BU MĂ©decine pharmacie (861942103) / SudocPARIS-BIUM (751062103) / SudocSudocFranceF
Influence du traitement par ventilation en pression positive continue sur l'incidence des complications cardiovasculaires du syndrome d'apnées obstructives du sommeil
POITIERS-BU MĂ©decine pharmacie (861942103) / SudocPARIS-BIUM (751062103) / SudocSudocFranceF
Le syndrome d'apnées du sommeil positionnel (prévalence et caractéristiques)
POITIERS-BU MĂ©decine pharmacie (861942103) / SudocSudocFranceF
Syndrome d'apnées-hypopnées du sommeil et médecine générale (étude prospective à propos de 579 questionnaires de médecins généralistes)
POITIERS-BU MĂ©decine pharmacie (861942103) / SudocPARIS-BIUM (751062103) / SudocSudocFranceF
Modifications des résistances des voies aériennes supérieures au cours du ronflement
POITIERS-BU MĂ©decine pharmacie (861942103) / SudocPARIS-BIUM (751062103) / SudocSudocFranceF